[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Point of Care Infectious Disease Testing Market Insights, Forecast to 2029

December 2023 | 115 pages | ID: GABCB1B5CF28EN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for Point of Care Infectious Disease Testing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Point of Care Infectious Disease Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Point of Care Infectious Disease Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Point of Care Infectious Disease Testing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Point of Care Infectious Disease Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Point of Care Infectious Disease Testing revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Alere, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers, BD, Chembio Diagnostics, Trinity Biotech, Cardinal Health and Quest Diagnostics, etc.

By Company
  • Alere
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • BD
  • Chembio Diagnostics
  • Trinity Biotech
  • Cardinal Health
  • Quest Diagnostics
  • Bio-Rad Labs
  • bioMйrieux
  • Sight Diagnostics
  • Gene POC
  • Trivitron Healthcare
  • OJ-Bio
  • Ortho-Clinical Diagnostics
Segment by Type
  • HIV POC
  • HBV POC
  • Pneumonia or Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV) POC
  • HPV POC
  • Influenza POC
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Home
  • Others
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East, Africa, and Latin America
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Point of Care Infectious Disease Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Point of Care Infectious Disease Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Point of Care Infectious Disease Testing revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Point of Care Infectious Disease Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  1.2.2 HIV POC
  1.2.3 HBV POC
  1.2.4 Pneumonia or Streptococcus Associated Infections
  1.2.5 Respiratory Syncytial Virus (RSV) POC
  1.2.6 HPV POC
  1.2.7 Influenza POC
  1.2.8 Others
1.3 Market by Application
  1.3.1 Global Point of Care Infectious Disease Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Home
  1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Point of Care Infectious Disease Testing Market Perspective (2018-2029)
2.2 Global Point of Care Infectious Disease Testing Growth Trends by Region
  2.2.1 Point of Care Infectious Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Point of Care Infectious Disease Testing Historic Market Size by Region (2018-2023)
  2.2.3 Point of Care Infectious Disease Testing Forecasted Market Size by Region (2024-2029)
2.3 Point of Care Infectious Disease Testing Market Dynamics
  2.3.1 Point of Care Infectious Disease Testing Industry Trends
  2.3.2 Point of Care Infectious Disease Testing Market Drivers
  2.3.3 Point of Care Infectious Disease Testing Market Challenges
  2.3.4 Point of Care Infectious Disease Testing Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Revenue Point of Care Infectious Disease Testing by Players
  3.1.1 Global Point of Care Infectious Disease Testing Revenue by Players (2018-2023)
  3.1.2 Global Point of Care Infectious Disease Testing Revenue Market Share by Players (2018-2023)
3.2 Global Point of Care Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Point of Care Infectious Disease Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Point of Care Infectious Disease Testing Market Concentration Ratio
  3.4.1 Global Point of Care Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Testing Revenue in 2022
3.5 Global Key Players of Point of Care Infectious Disease Testing Head office and Area Served
3.6 Global Key Players of Point of Care Infectious Disease Testing, Product and Application
3.7 Global Key Players of Point of Care Infectious Disease Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 POINT OF CARE INFECTIOUS DISEASE TESTING BREAKDOWN DATA BY TYPE

4.1 Global Point of Care Infectious Disease Testing Historic Market Size by Type (2018-2023)
4.2 Global Point of Care Infectious Disease Testing Forecasted Market Size by Type (2024-2029)

5 POINT OF CARE INFECTIOUS DISEASE TESTING BREAKDOWN DATA BY APPLICATION

5.1 Global Point of Care Infectious Disease Testing Historic Market Size by Application (2018-2023)
5.2 Global Point of Care Infectious Disease Testing Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Point of Care Infectious Disease Testing Market Size (2018-2029)
6.2 North America Point of Care Infectious Disease Testing Market Size by Type
  6.2.1 North America Point of Care Infectious Disease Testing Market Size by Type (2018-2023)
  6.2.2 North America Point of Care Infectious Disease Testing Market Size by Type (2024-2029)
  6.2.3 North America Point of Care Infectious Disease Testing Market Share by Type (2018-2029)
6.3 North America Point of Care Infectious Disease Testing Market Size by Application
  6.3.1 North America Point of Care Infectious Disease Testing Market Size by Application (2018-2023)
  6.3.2 North America Point of Care Infectious Disease Testing Market Size by Application (2024-2029)
  6.3.3 North America Point of Care Infectious Disease Testing Market Share by Application (2018-2029)
6.4 North America Point of Care Infectious Disease Testing Market Size by Country
  6.4.1 North America Point of Care Infectious Disease Testing Market Size by Country: 2018 VS 2022 VS 2029
  6.4.2 North America Point of Care Infectious Disease Testing Market Size by Country (2018-2023)
  6.4.3 North America Point of Care Infectious Disease Testing Market Size by Country (2024-2029)
  6.4.4 United States
  6.4.5 Canada

7 EUROPE

7.1 Europe Point of Care Infectious Disease Testing Market Size (2018-2029)
7.2 Europe Point of Care Infectious Disease Testing Market Size by Type
  7.2.1 Europe Point of Care Infectious Disease Testing Market Size by Type (2018-2023)
  7.2.2 Europe Point of Care Infectious Disease Testing Market Size by Type (2024-2029)
  7.2.3 Europe Point of Care Infectious Disease Testing Market Share by Type (2018-2029)
7.3 Europe Point of Care Infectious Disease Testing Market Size by Application
  7.3.1 Europe Point of Care Infectious Disease Testing Market Size by Application (2018-2023)
  7.3.2 Europe Point of Care Infectious Disease Testing Market Size by Application (2024-2029)
  7.3.3 Europe Point of Care Infectious Disease Testing Market Share by Application (2018-2029)
7.4 Europe Point of Care Infectious Disease Testing Market Size by Country
  7.4.1 Europe Point of Care Infectious Disease Testing Market Size by Country: 2018 VS 2022 VS 2029
  7.4.2 Europe Point of Care Infectious Disease Testing Market Size by Country (2018-2023)
  7.4.3 Europe Point of Care Infectious Disease Testing Market Size by Country (2024-2029)
  7.4.3 Germany
  7.4.4 France
  7.4.5 U.K.
  7.4.6 Italy
  7.4.7 Russia
  7.4.8 Nordic Countries

8 CHINA

8.1 China Point of Care Infectious Disease Testing Market Size (2018-2029)
8.2 China Point of Care Infectious Disease Testing Market Size by Type
  8.2.1 China Point of Care Infectious Disease Testing Market Size by Type (2018-2023)
  8.2.2 China Point of Care Infectious Disease Testing Market Size by Type (2024-2029)
  8.2.3 China Point of Care Infectious Disease Testing Market Share by Type (2018-2029)
8.3 China Point of Care Infectious Disease Testing Market Size by Application
  8.3.1 China Point of Care Infectious Disease Testing Market Size by Application (2018-2023)
  8.3.2 China Point of Care Infectious Disease Testing Market Size by Application (2024-2029)
  8.3.3 China Point of Care Infectious Disease Testing Market Share by Application (2018-2029)

9 ASIA (EXCLUDING CHINA)

9.1 Asia Point of Care Infectious Disease Testing Market Size (2018-2029)
9.2 Asia Point of Care Infectious Disease Testing Market Size by Type
  9.2.1 Asia Point of Care Infectious Disease Testing Market Size by Type (2018-2023)
  9.2.2 Asia Point of Care Infectious Disease Testing Market Size by Type (2024-2029)
  9.2.3 Asia Point of Care Infectious Disease Testing Market Share by Type (2018-2029)
9.3 Asia Point of Care Infectious Disease Testing Market Size by Application
  9.3.1 Asia Point of Care Infectious Disease Testing Market Size by Application (2018-2023)
  9.3.2 Asia Point of Care Infectious Disease Testing Market Size by Application (2024-2029)
  9.3.3 Asia Point of Care Infectious Disease Testing Market Share by Application (2018-2029)
9.4 Asia Point of Care Infectious Disease Testing Market Size by Region
  9.4.1 Asia Point of Care Infectious Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
  9.4.2 Asia Point of Care Infectious Disease Testing Market Size by Region (2018-2023)
  9.4.3 Asia Point of Care Infectious Disease Testing Market Size by Region (2024-2029)
  9.4.4 Japan
  9.4.5 South Korea
  9.4.6 China Taiwan
  9.4.7 Southeast Asia
  9.4.8 India
  9.4.9 Australia

10 MIDDLE EAST, AFRICA, AND LATIN AMERICA

10.1 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Type
  10.2.1 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Type (2018-2023)
  10.2.2 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Type (2024-2029)
  10.2.3 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Application
  10.3.1 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Application (2018-2023)
  10.3.2 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Application (2024-2029)
  10.3.3 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Country
  10.4.1 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Country: 2018 VS 2022 VS 2029
  10.4.2 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Country (2018-2023)
  10.4.3 Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Country (2024-2029)
  10.4.4 Brazil
  10.4.5 Mexico
  10.4.6 Turkey
  10.4.7 Saudi Arabia
  10.4.8 Israel
  10.4.9 GCC Countries

11 KEY PLAYERS PROFILES

11.1 Alere
  11.1.1 Alere Company Details
  11.1.2 Alere Business Overview
  11.1.3 Alere Point of Care Infectious Disease Testing Introduction
  11.1.4 Alere Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.1.5 Alere Recent Developments
11.2 Thermo Fisher Scientific
  11.2.1 Thermo Fisher Scientific Company Details
  11.2.2 Thermo Fisher Scientific Business Overview
  11.2.3 Thermo Fisher Scientific Point of Care Infectious Disease Testing Introduction
  11.2.4 Thermo Fisher Scientific Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.2.5 Thermo Fisher Scientific Recent Developments
11.3 F. Hoffmann-La Roche
  11.3.1 F. Hoffmann-La Roche Company Details
  11.3.2 F. Hoffmann-La Roche Business Overview
  11.3.3 F. Hoffmann-La Roche Point of Care Infectious Disease Testing Introduction
  11.3.4 F. Hoffmann-La Roche Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.3.5 F. Hoffmann-La Roche Recent Developments
11.4 Siemens Healthineers
  11.4.1 Siemens Healthineers Company Details
  11.4.2 Siemens Healthineers Business Overview
  11.4.3 Siemens Healthineers Point of Care Infectious Disease Testing Introduction
  11.4.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.4.5 Siemens Healthineers Recent Developments
11.5 BD
  11.5.1 BD Company Details
  11.5.2 BD Business Overview
  11.5.3 BD Point of Care Infectious Disease Testing Introduction
  11.5.4 BD Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.5.5 BD Recent Developments
11.6 Chembio Diagnostics
  11.6.1 Chembio Diagnostics Company Details
  11.6.2 Chembio Diagnostics Business Overview
  11.6.3 Chembio Diagnostics Point of Care Infectious Disease Testing Introduction
  11.6.4 Chembio Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.6.5 Chembio Diagnostics Recent Developments
11.7 Trinity Biotech
  11.7.1 Trinity Biotech Company Details
  11.7.2 Trinity Biotech Business Overview
  11.7.3 Trinity Biotech Point of Care Infectious Disease Testing Introduction
  11.7.4 Trinity Biotech Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.7.5 Trinity Biotech Recent Developments
11.8 Cardinal Health
  11.8.1 Cardinal Health Company Details
  11.8.2 Cardinal Health Business Overview
  11.8.3 Cardinal Health Point of Care Infectious Disease Testing Introduction
  11.8.4 Cardinal Health Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.8.5 Cardinal Health Recent Developments
11.9 Quest Diagnostics
  11.9.1 Quest Diagnostics Company Details
  11.9.2 Quest Diagnostics Business Overview
  11.9.3 Quest Diagnostics Point of Care Infectious Disease Testing Introduction
  11.9.4 Quest Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.9.5 Quest Diagnostics Recent Developments
11.10 Bio-Rad Labs
  11.10.1 Bio-Rad Labs Company Details
  11.10.2 Bio-Rad Labs Business Overview
  11.10.3 Bio-Rad Labs Point of Care Infectious Disease Testing Introduction
  11.10.4 Bio-Rad Labs Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.10.5 Bio-Rad Labs Recent Developments
11.11 bioMйrieux
  11.11.1 bioMйrieux Company Details
  11.11.2 bioMйrieux Business Overview
  11.11.3 bioMйrieux Point of Care Infectious Disease Testing Introduction
  11.11.4 bioMйrieux Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.11.5 bioMйrieux Recent Developments
11.12 Sight Diagnostics
  11.12.1 Sight Diagnostics Company Details
  11.12.2 Sight Diagnostics Business Overview
  11.12.3 Sight Diagnostics Point of Care Infectious Disease Testing Introduction
  11.12.4 Sight Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.12.5 Sight Diagnostics Recent Developments
11.13 Gene POC
  11.13.1 Gene POC Company Details
  11.13.2 Gene POC Business Overview
  11.13.3 Gene POC Point of Care Infectious Disease Testing Introduction
  11.13.4 Gene POC Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.13.5 Gene POC Recent Developments
11.14 Trivitron Healthcare
  11.14.1 Trivitron Healthcare Company Details
  11.14.2 Trivitron Healthcare Business Overview
  11.14.3 Trivitron Healthcare Point of Care Infectious Disease Testing Introduction
  11.14.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.14.5 Trivitron Healthcare Recent Developments
11.15 OJ-Bio
  11.15.1 OJ-Bio Company Details
  11.15.2 OJ-Bio Business Overview
  11.15.3 OJ-Bio Point of Care Infectious Disease Testing Introduction
  11.15.4 OJ-Bio Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.15.5 OJ-Bio Recent Developments
11.16 Ortho-Clinical Diagnostics
  11.16.1 Ortho-Clinical Diagnostics Company Details
  11.16.2 Ortho-Clinical Diagnostics Business Overview
  11.16.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Introduction
  11.16.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.16.5 Ortho-Clinical Diagnostics Recent Developments

12 ANALYST'S VIEWPOINTS/CONCLUSIONS

13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global Point of Care Infectious Disease Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of HIV POC
Table 3. Key Players of HBV POC
Table 4. Key Players of Pneumonia or Streptococcus Associated Infections
Table 5. Key Players of Respiratory Syncytial Virus (RSV) POC
Table 6. Key Players of HPV POC
Table 7. Key Players of Influenza POC
Table 8. Key Players of Others
Table 9. Global Point of Care Infectious Disease Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 10. Global Point of Care Infectious Disease Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Point of Care Infectious Disease Testing Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Point of Care Infectious Disease Testing Market Share by Region (2018-2023)
Table 13. Global Point of Care Infectious Disease Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Point of Care Infectious Disease Testing Market Share by Region (2024-2029)
Table 15. Point of Care Infectious Disease Testing Market Trends
Table 16. Point of Care Infectious Disease Testing Market Drivers
Table 17. Point of Care Infectious Disease Testing Market Challenges
Table 18. Point of Care Infectious Disease Testing Market Restraints
Table 19. Global Point of Care Infectious Disease Testing Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Point of Care Infectious Disease Testing Revenue Share by Players (2018-2023)
Table 21. Global Top Point of Care Infectious Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Infectious Disease Testing as of 2022)
Table 22. Global Point of Care Infectious Disease Testing Industry Ranking 2021 VS 2022 VS 2023
Table 23. Global 5 Largest Players Market Share by Point of Care Infectious Disease Testing Revenue (CR5 and HHI) & (2018-2023)
Table 24. Global Key Players of Point of Care Infectious Disease Testing, Headquarters and Area Served
Table 25. Global Key Players of Point of Care Infectious Disease Testing, Product and Application
Table 26. Global Key Players of Point of Care Infectious Disease Testing, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Point of Care Infectious Disease Testing Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Point of Care Infectious Disease Testing Revenue Market Share by Type (2018-2023)
Table 30. Global Point of Care Infectious Disease Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Point of Care Infectious Disease Testing Revenue Market Share by Type (2024-2029)
Table 32. Global Point of Care Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Point of Care Infectious Disease Testing Revenue Share by Application (2018-2023)
Table 34. Global Point of Care Infectious Disease Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Point of Care Infectious Disease Testing Revenue Share by Application (2024-2029)
Table 36. North America Point of Care Infectious Disease Testing Market Size by Type (2018-2023) & (US$ Million)
Table 37. North America Point of Care Infectious Disease Testing Market Size by Type (2024-2029) & (US$ Million)
Table 38. North America Point of Care Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
Table 39. North America Point of Care Infectious Disease Testing Market Size by Application (2024-2029) & (US$ Million)
Table 40. North America Point of Care Infectious Disease Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. North America Point of Care Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
Table 42. North America Point of Care Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
Table 43. Europe Point of Care Infectious Disease Testing Market Size by Type (2018-2023) & (US$ Million)
Table 44. Europe Point of Care Infectious Disease Testing Market Size by Type (2024-2029) & (US$ Million)
Table 45. Europe Point of Care Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
Table 46. Europe Point of Care Infectious Disease Testing Market Size by Application (2024-2029) & (US$ Million)
Table 47. Europe Point of Care Infectious Disease Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Europe Point of Care Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
Table 49. Europe Point of Care Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
Table 50. China Point of Care Infectious Disease Testing Market Size by Type (2018-2023) & (US$ Million)
Table 51. China Point of Care Infectious Disease Testing Market Size by Type (2024-2029) & (US$ Million)
Table 52. China Point of Care Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
Table 53. China Point of Care Infectious Disease Testing Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Point of Care Infectious Disease Testing Market Size by Type (2018-2023) & (US$ Million)
Table 55. Asia Point of Care Infectious Disease Testing Market Size by Type (2024-2029) & (US$ Million)
Table 56. Asia Point of Care Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
Table 57. Asia Point of Care Infectious Disease Testing Market Size by Application (2024-2029) & (US$ Million)
Table 58. Asia Point of Care Infectious Disease Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia Point of Care Infectious Disease Testing Market Size by Region (2018-2023) & (US$ Million)
Table 60. Asia Point of Care Infectious Disease Testing Market Size by Region (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Type (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Type (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Application (2024-2029) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
Table 68. Alere Company Details
Table 69. Alere Business Overview
Table 70. Alere Point of Care Infectious Disease Testing Product
Table 71. Alere Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 72. Alere Recent Developments
Table 73. Thermo Fisher Scientific Company Details
Table 74. Thermo Fisher Scientific Business Overview
Table 75. Thermo Fisher Scientific Point of Care Infectious Disease Testing Product
Table 76. Thermo Fisher Scientific Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 77. Thermo Fisher Scientific Recent Developments
Table 78. F. Hoffmann-La Roche Company Details
Table 79. F. Hoffmann-La Roche Business Overview
Table 80. F. Hoffmann-La Roche Point of Care Infectious Disease Testing Product
Table 81. F. Hoffmann-La Roche Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 82. F. Hoffmann-La Roche Recent Developments
Table 83. Siemens Healthineers Company Details
Table 84. Siemens Healthineers Business Overview
Table 85. Siemens Healthineers Point of Care Infectious Disease Testing Product
Table 86. Siemens Healthineers Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 87. Siemens Healthineers Recent Developments
Table 88. BD Company Details
Table 89. BD Business Overview
Table 90. BD Point of Care Infectious Disease Testing Product
Table 91. BD Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 92. BD Recent Developments
Table 93. Chembio Diagnostics Company Details
Table 94. Chembio Diagnostics Business Overview
Table 95. Chembio Diagnostics Point of Care Infectious Disease Testing Product
Table 96. Chembio Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 97. Chembio Diagnostics Recent Developments
Table 98. Trinity Biotech Company Details
Table 99. Trinity Biotech Business Overview
Table 100. Trinity Biotech Point of Care Infectious Disease Testing Product
Table 101. Trinity Biotech Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 102. Trinity Biotech Recent Developments
Table 103. Cardinal Health Company Details
Table 104. Cardinal Health Business Overview
Table 105. Cardinal Health Point of Care Infectious Disease Testing Product
Table 106. Cardinal Health Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 107. Cardinal Health Recent Developments
Table 108. Quest Diagnostics Company Details
Table 109. Quest Diagnostics Business Overview
Table 110. Quest Diagnostics Point of Care Infectious Disease Testing Product
Table 111. Quest Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 112. Quest Diagnostics Recent Developments
Table 113. Bio-Rad Labs Company Details
Table 114. Bio-Rad Labs Business Overview
Table 115. Bio-Rad Labs Point of Care Infectious Disease Testing Product
Table 116. Bio-Rad Labs Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 117. Bio-Rad Labs Recent Developments
Table 118. bioMйrieux Company Details
Table 119. bioMйrieux Business Overview
Table 120. bioMйrieux Point of Care Infectious Disease Testing Product
Table 121. bioMйrieux Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 122. bioMйrieux Recent Developments
Table 123. Sight Diagnostics Company Details
Table 124. Sight Diagnostics Business Overview
Table 125. Sight Diagnostics Point of Care Infectious Disease Testing Product
Table 126. Sight Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 127. Sight Diagnostics Recent Developments
Table 128. Gene POC Company Details
Table 129. Gene POC Business Overview
Table 130. Gene POC Point of Care Infectious Disease Testing Product
Table 131. Gene POC Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 132. Gene POC Recent Developments
Table 133. Trivitron Healthcare Company Details
Table 134. Trivitron Healthcare Business Overview
Table 135. Trivitron Healthcare Point of Care Infectious Disease Testing Product
Table 136. Trivitron Healthcare Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 137. Trivitron Healthcare Recent Developments
Table 138. OJ-Bio Company Details
Table 139. OJ-Bio Business Overview
Table 140. OJ-Bio Point of Care Infectious Disease Testing Product
Table 141. OJ-Bio Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 142. OJ-Bio Recent Developments
Table 143. Ortho-Clinical Diagnostics Company Details
Table 144. Ortho-Clinical Diagnostics Business Overview
Table 145. Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Product
Table 146. Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 147. Ortho-Clinical Diagnostics Recent Developments
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Point of Care Infectious Disease Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Point of Care Infectious Disease Testing Market Share by Type: 2022 VS 2029
Figure 3. HIV POC Features
Figure 4. HBV POC Features
Figure 5. Pneumonia or Streptococcus Associated Infections Features
Figure 6. Respiratory Syncytial Virus (RSV) POC Features
Figure 7. HPV POC Features
Figure 8. Influenza POC Features
Figure 9. Others Features
Figure 10. Global Point of Care Infectious Disease Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Point of Care Infectious Disease Testing Market Share by Application: 2022 VS 2029
Figure 12. Hospitals Case Studies
Figure 13. Clinics Case Studies
Figure 14. Home Case Studies
Figure 15. Others Case Studies
Figure 16. Point of Care Infectious Disease Testing Report Years Considered
Figure 17. Global Point of Care Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Point of Care Infectious Disease Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Point of Care Infectious Disease Testing Market Share by Region: 2022 VS 2029
Figure 20. Global Point of Care Infectious Disease Testing Market Share by Players in 2022
Figure 21. Global Top Point of Care Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Infectious Disease Testing as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Point of Care Infectious Disease Testing Revenue in 2022
Figure 23. North America Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Point of Care Infectious Disease Testing Market Share by Type (2018-2029)
Figure 25. North America Point of Care Infectious Disease Testing Market Share by Application (2018-2029)
Figure 26. North America Point of Care Infectious Disease Testing Market Share by Country (2018-2029)
Figure 27. United States Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Canada Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Point of Care Infectious Disease Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 30. Europe Point of Care Infectious Disease Testing Market Share by Type (2018-2029)
Figure 31. Europe Point of Care Infectious Disease Testing Market Share by Application (2018-2029)
Figure 32. Europe Point of Care Infectious Disease Testing Market Share by Country (2018-2029)
Figure 33. Germany Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. France Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. U.K. Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Italy Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Russia Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Nordic Countries Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. China Point of Care Infectious Disease Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 40. China Point of Care Infectious Disease Testing Market Share by Type (2018-2029)
Figure 41. China Point of Care Infectious Disease Testing Market Share by Application (2018-2029)
Figure 42. Asia Point of Care Infectious Disease Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 43. Asia Point of Care Infectious Disease Testing Market Share by Type (2018-2029)
Figure 44. Asia Point of Care Infectious Disease Testing Market Share by Application (2018-2029)
Figure 45. Asia Point of Care Infectious Disease Testing Market Share by Region (2018-2029)
Figure 46. Japan Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. South Korea Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. China Taiwan Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Southeast Asia Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. India Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Australia Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Share by Type (2018-2029)
Figure 54. Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Share by Application (2018-2029)
Figure 55. Middle East, Africa, and Latin America Point of Care Infectious Disease Testing Market Share by Country (2018-2029)
Figure 56. Brazil Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Mexico Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Turkey Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Israel Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. GCC Countries Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 62. Alere Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 64. F. Hoffmann-La Roche Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 65. Siemens Healthineers Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 66. BD Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 67. Chembio Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 68. Trinity Biotech Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 69. Cardinal Health Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 70. Quest Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 71. Bio-Rad Labs Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 72. bioMйrieux Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 73. Sight Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 74. Gene POC Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 75. Trivitron Healthcare Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 76. OJ-Bio Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 77. Ortho-Clinical Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed


More Publications